长期疗效-话题@MedSci

#长期疗效#

89篇内容 | 1525人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1553521, encodeId=60e115535214f, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=JEADV:富马酸酯或阿维A联合12周PUVA治疗掌跖脓疱病的短期和长期疗效分析, objectType=article, longId=216684, objectId=520921668417, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=520921668417, replyNumber=0, likeNumber=32, createdTime=2021-09-05, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=520921668417, moduleTitle=JEADV:富马酸酯或阿维A联合12周PUVA治疗掌跖脓疱病的短期和长期疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=520921668417)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553520, encodeId=d6dc155352016, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Eur J Cancer：克唑替尼治疗晚期或转移性炎性肌纤维母细胞瘤的长期疗效, objectType=article, longId=215964, objectId=9597215964de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9597215964de, replyNumber=0, likeNumber=33, createdTime=2021-08-20, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9597215964de, moduleTitle=Eur J Cancer：克唑替尼治疗晚期或转移性炎性肌纤维母细胞瘤的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9597215964de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553519, encodeId=54041553519aa, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=J Clin Oncol：Acalabrutinib和依鲁替尼用于CLL的长期疗效PK！, objectType=article, longId=214991, objectId=9fdb214991ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fdb214991ba, replyNumber=0, likeNumber=37, createdTime=2021-07-30, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fdb214991ba, moduleTitle=J Clin Oncol：Acalabrutinib和依鲁替尼用于CLL的长期疗效PK！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fdb214991ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553518, encodeId=7d6e155351856, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Neuromodulation:经颅直流电刺激预防发作性偏头痛的长期疗效：一项随机对照试验的结果, objectType=article, longId=214767, objectId=1f3d214e67f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f3d214e67f1, replyNumber=0, likeNumber=38, createdTime=2021-07-26, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f3d214e67f1, moduleTitle=Neuromodulation:经颅直流电刺激预防发作性偏头痛的长期疗效：一项随机对照试验的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f3d214e67f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553517, encodeId=8284155351ee0, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=J Dermatol：布罗达单抗治疗斑块状银屑病伴/不伴银屑病关节炎具有长期疗效和安全性, objectType=article, longId=210780, objectId=a3b5210e804c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3b5210e804c, replyNumber=0, likeNumber=48, createdTime=2021-05-05, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3b5210e804c, moduleTitle=J Dermatol：布罗达单抗治疗斑块状银屑病伴/不伴银屑病关节炎具有长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3b5210e804c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553516, encodeId=491315535168f, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Blood：艾米珠单抗预防用于A型血友病患者的长期疗效, objectType=article, longId=210677, objectId=b92d2106e75e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b92d2106e75e, replyNumber=0, likeNumber=35, createdTime=2021-05-01, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b92d2106e75e, moduleTitle=Blood：艾米珠单抗预防用于A型血友病患者的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b92d2106e75e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553515, encodeId=56bc1553515c9, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Eur J Cancer：复发/难治性费城染色体阳性ALL患者采用博纳吐单抗治疗的长期疗效, objectType=article, longId=207387, objectId=dc5120e387fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc5120e387fe, replyNumber=0, likeNumber=35, createdTime=2021-02-22, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc5120e387fe, moduleTitle=Eur J Cancer：复发/难治性费城染色体阳性ALL患者采用博纳吐单抗治疗的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc5120e387fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553514, encodeId=624d155351401, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=BRAIN：KMT2B相关疾病-表型谱的扩展和深部脑刺激的长期疗效, objectType=article, longId=205156, objectId=1dcc205156c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dcc205156c1, replyNumber=0, likeNumber=30, createdTime=2021-01-02, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dcc205156c1, moduleTitle=BRAIN：KMT2B相关疾病-表型谱的扩展和深部脑刺激的长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1dcc205156c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553513, encodeId=9b5f15535134e, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=ASH 2020：Calquence治疗MCL的长期疗效和耐受性, objectType=article, longId=204329, objectId=16ec20432946, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16ec20432946, replyNumber=0, likeNumber=34, createdTime=2020-12-10, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16ec20432946, moduleTitle=ASH 2020：Calquence治疗MCL的长期疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16ec20432946)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553512, encodeId=882a15535125a, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=EADV 2020：JAK抑制剂Baricitinib治疗湿疹，展现长期疗效和安全性, objectType=article, longId=202999, objectId=8918202999cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8918202999cd, replyNumber=0, likeNumber=26, createdTime=2020-11-08, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8918202999cd, moduleTitle=EADV 2020：JAK抑制剂Baricitinib治疗湿疹，展现长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8918202999cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553511, encodeId=16c01553511d5, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=ViiV的两药HIV疗法显示出长期疗效, objectType=article, longId=202000, objectId=90d2202000cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90d2202000cd, replyNumber=0, likeNumber=53, createdTime=2020-10-13, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90d2202000cd, moduleTitle=ViiV的两药HIV疗法显示出长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90d2202000cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553510, encodeId=99261553510af, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Lancet oncol：纳武单抗维持高危黑色素瘤术后辅助治疗的长期疗效明显优于伊匹单抗, objectType=article, longId=201125, objectId=c5a52011256e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5a52011256e, replyNumber=0, likeNumber=32, createdTime=2020-09-25, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5a52011256e, moduleTitle=Lancet oncol：纳武单抗维持高危黑色素瘤术后辅助治疗的长期疗效明显优于伊匹单抗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5a52011256e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553509, encodeId=de281553509ea, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Immunol Lett：过敏性鼻炎中Omalizumab的长期疗效如何？, objectType=article, longId=200537, objectId=472f20053e7b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=472f20053e7b, replyNumber=0, likeNumber=31, createdTime=2020-09-12, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=472f20053e7b, moduleTitle=Immunol Lett：过敏性鼻炎中Omalizumab的长期疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=472f20053e7b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553508, encodeId=5f5d1553508dd, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Ann Rheum Dis：对秋水仙碱耐药的家族性地中海热患者使用卡那单抗的长期疗效和安全性, objectType=article, longId=196491, objectId=400119649139, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=400119649139, replyNumber=0, likeNumber=30, createdTime=2020-06-27, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=400119649139, moduleTitle=Ann Rheum Dis：对秋水仙碱耐药的家族性地中海热患者使用卡那单抗的长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=400119649139)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553507, encodeId=7c8b155350ec8, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Ann Rheum Dis：苏金单抗对难治性白塞病黏膜和关节表型的长期疗效和安全性, objectType=article, longId=193763, objectId=6f30193e6349, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f30193e6349, replyNumber=0, likeNumber=37, createdTime=2020-05-10, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f30193e6349, moduleTitle=Ann Rheum Dis：苏金单抗对难治性白塞病黏膜和关节表型的长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f30193e6349)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553506, encodeId=bd741553506c7, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Sex Med：每日和按需使用他达拉非治疗勃起功能障碍的长期疗效和耐受性, objectType=article, longId=192980, objectId=65b21929803d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65b21929803d, replyNumber=0, likeNumber=33, createdTime=2020-04-27, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65b21929803d, moduleTitle=Sex Med：每日和按需使用他达拉非治疗勃起功能障碍的长期疗效和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65b21929803d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553505, encodeId=a9db1553505f4, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！, objectType=article, longId=187425, objectId=b82918e4252e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b82918e4252e, replyNumber=0, likeNumber=25, createdTime=2020-02-06, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b82918e4252e, moduleTitle=Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b82918e4252e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553504, encodeId=1e6815535045e, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=J Endod：成熟恒牙牙髓切断术的长期疗效观察, objectType=article, longId=186705, objectId=d1bd186e0510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1bd186e0510, replyNumber=0, likeNumber=38, createdTime=2020-01-26, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1bd186e0510, moduleTitle=J Endod：成熟恒牙牙髓切断术的长期疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1bd186e0510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553503, encodeId=39e815535033b, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=JCC：异基因骨髓间充质基质细胞疗法在治疗肛瘘克罗恩病患者的长期疗效分析, objectType=article, longId=185366, objectId=46fb18536608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46fb18536608, replyNumber=0, likeNumber=43, createdTime=2019-12-29, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46fb18536608, moduleTitle=JCC：异基因骨髓间充质基质细胞疗法在治疗肛瘘克罗恩病患者的长期疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46fb18536608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1553502, encodeId=2dc8155350237, content=<a href='/topic/show?id=3b409e02804' target=_blank style='color:#2F92EE;'>#长期疗效#</a>, objectTitle=Stroke：烟雾病儿童间接旁路术后长期疗效, objectType=article, longId=180046, objectId=01e0180046ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01e0180046ab, replyNumber=0, likeNumber=37, createdTime=2019-09-27, rootId=0, userName=gjsgj, userId=fe2a14383573, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01e0180046ab, moduleTitle=Stroke：烟雾病儿童间接旁路术后长期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01e0180046ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

长期疗效

2020-05-29

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

JEADV:富马酸酯或阿维A联合12周PUVA治疗掌跖脓疱病的短期和长期疗效分析

2021-09-05

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Eur J Cancer：克唑替尼治疗晚期或转移性炎性肌纤维母细胞瘤的长期疗效

2021-08-20

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

J Clin Oncol：Acalabrutinib和依鲁替尼用于CLL的长期疗效PK！

2021-07-30

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Neuromodulation:经颅直流电刺激预防发作性偏头痛的长期疗效：一项随机对照试验的结果

2021-07-26

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

J Dermatol：布罗达单抗治疗斑块状银屑病伴/不伴银屑病关节炎具有长期疗效和安全性

2021-05-05

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Blood：艾米珠单抗预防用于A型血友病患者的长期疗效

2021-05-01

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Eur J Cancer：复发/难治性费城染色体阳性ALL患者采用博纳吐单抗治疗的长期疗效

2021-02-22

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

BRAIN：KMT2B相关疾病-表型谱的扩展和深部脑刺激的长期疗效

2021-01-02

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

ASH 2020：Calquence治疗MCL的长期疗效和耐受性

2020-12-10

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

EADV 2020：JAK抑制剂Baricitinib治疗湿疹，展现长期疗效和安全性

2020-11-08

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

ViiV的两药HIV疗法显示出长期疗效

2020-10-13

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Lancet oncol：纳武单抗维持高危黑色素瘤术后辅助治疗的长期疗效明显优于伊匹单抗

2020-09-25

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Immunol Lett：过敏性鼻炎中Omalizumab的长期疗效如何？

2020-09-12

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Ann Rheum Dis：对秋水仙碱耐药的家族性地中海热患者使用卡那单抗的长期疗效和安全性

2020-06-27

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Ann Rheum Dis：苏金单抗对难治性白塞病黏膜和关节表型的长期疗效和安全性

2020-05-10

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Sex Med：每日和按需使用他达拉非治疗勃起功能障碍的长期疗效和耐受性

2020-04-27

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Lancet haematol：Ropeginterferon alfa-2b对比羟基脲用于真性红细胞增多症的长期疗效！

2020-02-06

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

J Endod：成熟恒牙牙髓切断术的长期疗效观察

2020-01-26

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

JCC：异基因骨髓间充质基质细胞疗法在治疗肛瘘克罗恩病患者的长期疗效分析

2019-12-29

gjsgj (审核中...)

前往app查看评论内容

#长期疗效#

Stroke：烟雾病儿童间接旁路术后长期疗效

2019-09-27

科室
- - 订阅+
  - 更多科室
工具
服务